Advisory Board January 26, 2026
OpenEvidence has become the most valuable healthcare AI company after raising $250 million at a $12 billion valuation, in today’s bite-sized hospital and health industry news from California, Florida, and Maryland.
- California: On Jan. 1, California ended coverage of GLP-1 drugs for obesity, though the state will still cover the medication for other health issues, such as type 2 diabetes, cardiovascular disease, and chronic kidney disease. According to the California Department of Health Care Services, the cost of covering GLP-1s for weight loss would have more than quadrupled to almost $800 million annually over four years if the state didn’t end Medi-Cal coverage for it. California joins several states, including New Hampshire, Pennsylvania, and South Carolina, in ending GLP-1...
Today's Sponsors
Today's Sponsor